BioCentury
ARTICLE | Company News

Bayer deal

October 6, 2008 7:00 AM UTC

Bayer acquired the 4% of its Schering Pharma subsidiary it did not already own for €98.98 per share, or about €756 million ($1.1 billion), in cash. The pharma acquired the majority of Schering in 2006...